UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus

Gastroenterology (New York, N.Y. 1943), 2020-12, Vol.159 (6), p.2116-2129.e4

2020

Volltextzugriff (PDF)

Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity

Gastroenterology (New York, N.Y. 1943), 2016-07, Vol.151 (1), p.120-129.e5

2016

Volltextzugriff (PDF)

A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2021-09, Vol.161 (3), p.837-852.e9

2021

Volltextzugriff (PDF)

Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study

Gastroenterology (New York, N.Y. 1943), 2018-11, Vol.155 (5), p.1416-1427

2018

Volltextzugriff (PDF)

Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

Gastroenterology (New York, N.Y. 1943), 2016-07, Vol.151 (1), p.97-109.e4

2016

Volltextzugriff (PDF)

Understanding Characteristics of Who Undergoes Testing Is Crucial for the Development of Diagnostic Strategies to Identify Individuals at Risk for Early-age Onset Colorectal Cancer

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.993-998

2021

Volltextzugriff (PDF)

IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (3), p.S11-S12

2022

Volltextzugriff (PDF)

Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts

Gastroenterology (New York, N.Y. 1943), 2018-12, Vol.155 (6), p.1720-1728.e4

2018

Volltextzugriff (PDF)

Su1510: IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-607-S-607

2022

Volltextzugriff (PDF)

21 WHAT IS THE MOST COST-EFFECTIVE POSITION OF VEDOLIZUMAB IN THE CURRENT TREATMENT ALGORITHM OF ULCERATIVE COLITIS?

Gastroenterology (New York, N.Y. 1943), 2018-01, Vol.154 (1), p.S66-S67

2018

Volltextzugriff (PDF)

Mo1708 – Comparison of Presenting Diagnoses and Symptoms in Patients with Young- Versus Older-Onset Colorectal Cancer

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-816-S-816

2019

Volltextzugriff (PDF)

Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.1682-1697.e1

2020

Volltextzugriff (PDF)

Mo1904 INSURANCE TYPE INFLUENCES INFLIXIMAB INITIATION TIME IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-971-S-972

2020

Volltextzugriff (PDF)

Mo1888 DECODING DELAYS IN BIOLOGIC AND SMALL MOLECULE INITIATION FOR PATIENTS WITH IBD: A QUALITATIVE ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-964-S-964

2020

Volltextzugriff (PDF)

732 PRIOR AUTHORIZATION REQUIREMENTS PROLONG BIOLOGIC INITIATION TIME AND INCREASE SERIOUS ADVERSE EVENTS AND CORTICOSTEROID DEPENDENCE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-147-S-148

2021

Volltextzugriff (PDF)

511 Determining the Optimal Position for Vedolizumab in the Current Treatment Paradigm for Ulcerative Colitis: A Markov Model

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S104-S104

2016

Volltextzugriff (PDF)

Sa1581: PATIENT PERCEPTIONS OF FACTORS CONTRIBUTING TO DELAYS IN BIOLOGIC AND SMALL MOLECULE INITIATION IN INFLAMMATORY BOWEL DISEASE: A QUALITATIVE ANALYSES FROM THE DECODE-IBD STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-424-S-424

2022

Volltextzugriff (PDF)

1111 - Incidence of and Risk Factors for Recurrent Diverticular Bleeding Among Patients with a Prior Episode of Diverticular Bleeding

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-220-S-221

2018

Volltextzugriff (PDF)

Sa1071 - Statin Use at the Time of Intra-Abdominal Surgery Reduces the Risk of Post-Operative Small Bowel Obstruction and Adhesion-Related Complications: A Populationrepresentative Cohort Study

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-229-S-230

2018

Volltextzugriff (PDF)

Mo1842 – Relative Hazard of Chronic Kidney Disease Among Patients with Inflammatory Bowel Disease Varies by Age

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-858-S-858

2019

Volltextzugriff (PDF)

Su1870 – Identifying the Optimal Treatment Sequence with Ustekinumab in Standard Treatment Algorithms for Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-643-S-644

2019

Volltextzugriff (PDF)

Mo1367 The Impact of JC Virus Antibody Testing on Treatment Selection in Patients With Crohn's Disease Who Are Primary Non-Responders to Infliximab: A Decision Analysis

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-648-S-648

2013

Volltextzugriff (PDF)

Sa1871 NETWORKS OF PATHOBIONTS IN THE TUMOUR MUCOSAL NICHE PREDICT SURVIVAL FOLLOWING COLORECTAL CANCER RESECTION

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-469-S-470

2023

Volltextzugriff (PDF)

Tu1845 COMPARATIVE EFFECTIVENESS OF SURVEILLANCE COLONOSCOPY TIMING ON COLORECTAL CANCER OUTCOMES (STAGE, TREATMENT, MORTALITY) IN A NATIONAL COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1185-S-1185

2020

Volltextzugriff (PDF)

Reduced Mortality Rates with Anti-Tumor Necrosis Factor Alpha Directed Therapy When Compared to Prolonged Corticosteroid Therapy for Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S64-S65

2017

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieGastroenterology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta.com
(41)
Elsevier ScienceDirect Journals Complete
(41)
NUS Single-Journal Subscriptions
(41)
IngentaConnect Journals
(14)
MEDLINE
(9)

Menü

Weitere Dienste

Einstellungen

Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus

Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity

A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease

Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study

Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

Understanding Characteristics of Who Undergoes Testing Is Crucial for the Development of Diagnostic Strategies to Identify Individuals at Risk for Early-age Onset Colorectal Cancer

IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS

Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts

Su1510: IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS

21 WHAT IS THE MOST COST-EFFECTIVE POSITION OF VEDOLIZUMAB IN THE CURRENT TREATMENT ALGORITHM OF ULCERATIVE COLITIS?

Mo1708 – Comparison of Presenting Diagnoses and Symptoms in Patients with Young- Versus Older-Onset Colorectal Cancer

Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data

Mo1904 INSURANCE TYPE INFLUENCES INFLIXIMAB INITIATION TIME IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Mo1888 DECODING DELAYS IN BIOLOGIC AND SMALL MOLECULE INITIATION FOR PATIENTS WITH IBD: A QUALITATIVE ANALYSIS

732 PRIOR AUTHORIZATION REQUIREMENTS PROLONG BIOLOGIC INITIATION TIME AND INCREASE SERIOUS ADVERSE EVENTS AND CORTICOSTEROID DEPENDENCE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

511 Determining the Optimal Position for Vedolizumab in the Current Treatment Paradigm for Ulcerative Colitis: A Markov Model

Sa1581: PATIENT PERCEPTIONS OF FACTORS CONTRIBUTING TO DELAYS IN BIOLOGIC AND SMALL MOLECULE INITIATION IN INFLAMMATORY BOWEL DISEASE: A QUALITATIVE ANALYSES FROM THE DECODE-IBD STUDY

1111 - Incidence of and Risk Factors for Recurrent Diverticular Bleeding Among Patients with a Prior Episode of Diverticular Bleeding

Sa1071 - Statin Use at the Time of Intra-Abdominal Surgery Reduces the Risk of Post-Operative Small Bowel Obstruction and Adhesion-Related Complications: A Populationrepresentative Cohort Study

Mo1842 – Relative Hazard of Chronic Kidney Disease Among Patients with Inflammatory Bowel Disease Varies by Age

Su1870 – Identifying the Optimal Treatment Sequence with Ustekinumab in Standard Treatment Algorithms for Crohn’s Disease

Mo1367 The Impact of JC Virus Antibody Testing on Treatment Selection in Patients With Crohn's Disease Who Are Primary Non-Responders to Infliximab: A Decision Analysis

Sa1871 NETWORKS OF PATHOBIONTS IN THE TUMOUR MUCOSAL NICHE PREDICT SURVIVAL FOLLOWING COLORECTAL CANCER RESECTION

Tu1845 COMPARATIVE EFFECTIVENESS OF SURVEILLANCE COLONOSCOPY TIMING ON COLORECTAL CANCER OUTCOMES (STAGE, TREATMENT, MORTALITY) IN A NATIONAL COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Reduced Mortality Rates with Anti-Tumor Necrosis Factor Alpha Directed Therapy When Compared to Prolonged Corticosteroid Therapy for Inflammatory Bowel Disease

Aktive Filter

Suchergebnisse filtern